These are some very bold claims with no explanation as to why you think this or how it will come to happen.
Do you think these approvals will happen without further studies? If so, why?
CHF will require further studies. Still waiting on the CLBP trial, that may have some surprising results I guess, fingers crossed.
Hopefully Novartis looks past the recent trial failures and decides to continue with the partnership, I'm surprised we haven't had any formal updates about that yet.
As far as the analysis of the covid trial goes, there may be some exciting results that weren't expected. But realistically they'll need to perform more studies to validate those findings.
I worry there doesn't seem to be a path for revenue in the short to medium term. Without a partnership, what are people's thoughts on the need for a cap raise?
Seeking Alpha hatchet job, page-212
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |